Nexstim

Update in progress

NXTMH.HE (Helsinki)

Company RatingNeutral
SectorHealthcare
IndustryMedical Devices

Nexstim Plc is a medical technology company focused on non-invasive brain stimulation. It develops and markets navigated transcranial magnetic stimulation (nTMS) systems, including the NBS System 6 for presurgical mapping of speech and motor areas, and its use in major depression, chronic unilateral neuropathic pain, and post‑operative upper-limb motor rehab. It serves universities and teaching hospitals worldwide, with partnerships with Sinaptica Therapeutics for Alzheimer's/MCI neuromodulation and Brainlab for motor and speech mapping. Founded 2000, Helsinki.

Company score

Sentiment: 0.50; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: 0.01; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: 0.23; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: 0.06; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: 0.09; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: 0.29; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive